Helicobacter hepaticus, a recently recognized bacterial pathogen, associated with chronic hepatitis and hepatocellular neoplasia in laboratory mice.
Rice
J M
JM
Laboratory of Comparative Carcinogenesis, National Cancer Institute, Frederick, Maryland, USA.
D018248:Adenoma, Liver Cell / Q000188:drug therapy / Q000382:microbiology*; D000658:Amoxicillin / Q000627:therapeutic use; D000818:Animals; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000994:Antitrichomonal Agents / Q000627:therapeutic use; D001729:Bismuth / Q000627:therapeutic use; D006528:Carcinoma, Hepatocellular / Q000188:drug therapy / Q000382:microbiology*; D004359:Drug Therapy, Combination; D016998:Helicobacter / Q000472:pathogenicity*; D016481:Helicobacter Infections / Q000188:drug therapy / Q000382:microbiology* / Q000635:transmission; D006520:Hepatitis, Animal / Q000188:drug therapy / Q000382:microbiology* / Q000635:transmission; D008113:Liver Neoplasms / Q000188:drug therapy / Q000382:microbiology*; D008795:Metronidazole / Q000627:therapeutic use; D051379:Mice; D008809:Mice, Inbred C3H; D008810:Mice, Inbred C57BL; D008811:Mice, Inbred DBA; D010406:Penicillins / Q000627:therapeutic use; D013752:Tetracycline / Q000627:therapeutic use
D000900:Anti-Bacterial Agents; D000994:Antitrichomonal Agents; D010406:Penicillins; D008795:Metronidazole; D000658:Amoxicillin; D013752:Tetracycline; D001729:Bismuth